
James Baron Wetmore MD
Associate Professor, Internal Medicine, University Kansas School of Medicine
Join to View Full Profile
701 Park AveShapiro 5 NephrologyMinneapolis, MN 55415
Phone+1 612-873-6988
Dr. Wetmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Nephrology, 2000 - 2005
- University of Alabama Medical CenterResidency, Internal Medicine, 1997 - 2000
- University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
- CA State Medical License 2000 - Present
- MN State Medical License 2013 - 2025
- KS State Medical License Active through 2013
- AL State Medical License 1998 - 2000
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- Effects of statins on kidney function in older adults.Michelle A Fravel, Michael E Ernst, Robyn L Woods, Suzanne G Orchard, Kevan R Polkinghorne
Journal of the American Geriatrics Society. 2025-04-01 - 1 citationsClassification of chronic kidney disease in older Australian adults by the CKD-EPI 2009 and 2021 equations: secondary analysis of ASPREE study data.Elisa K Bongetti, Rory Wolfe, James B Wetmore, Anne M Murray, Robyn L Woods
The Medical Journal of Australia. 2025-02-03 - Association Between Albuminuria and Glomerular Filtration Rate With Incident Frailty.Elisa K Bongetti, Anna L Wilkinson, James B Wetmore, Anne M Murray, Robyn L Woods
Kidney International Reports. 2025-02-01
Press Mentions
- ESKD Treatment Dropped Sharply During Height of COVID-19 PandemicSeptember 28th, 2021
- Highlights from the August 2021 IssueAugust 2nd, 2021
- Readmission Rates High for HD Patients After CVD HospitalizationMarch 6th, 2018
- Join now to see all
Grant Support
- Factors Associated With Warfarin Use In Dialysis Patients W/ Atrial FibrillationNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: